The ATS 2024 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in pediatrics and sleep disorders, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the conference website. For more information on these and other sessions to be presented May 17–22 in San Diego, visit the online Advance Program.
- A6. Role of Sex in Pulmonary Disease Across the Lifespan
- A11. Leveraging Multi-Omics to Advance Precision Medicine in Bronchopulmonary Dysplasia
- B6. Integrating Evidence from Randomized Trials and Observational Cohorts in Sleep Disordered Breathing
- B8. Severe Childhood Asthma: New Perspectives on Phenotypes, Management, and Disease Remission
- B90. Impact of the Gut-Lung Axis on Respiratory Health Across the Lifespan
- B92. CF in the Modulator Era: Where Do We Go from Here?
- C3. Pediatric Clinical Chest Rounds
- C85. ATS Documents: Advancing Science and Improving Clinical Practice
- C87. Machine Learning in Pediatric Pulmonology
- C88. Health Equity Across Pediatric Pulmonary Diseases
- C92. Substance Use Disorders in Pulmonary, Critical Care, and Sleep Medicine
- D7. Where Children Learn and Breathe: The Impact of School-Based Exposures on Childhood Respiratory Health
- PCC3. Pediatric Clinical Core Curriculum
Don’t Miss ATS 2024 On-Demand Highlights
Don’t forget that ATS 2024 Highlights: On-Demand are available to all conference registrants! On-Demand will give you access to the Opening Ceremony, Plenary session, 13 live-streamed sessions, including the Keynote Series, Clinical Year in Review, Adult Clinical Core Curriculum, and approximately 40 recorded sessions. The topics will cover ILD, Asthma, Health Equity, CF, and more. On-demand content will be accessible to all ATS 2024 full conference and on-demand registrants until March 2025.